Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD
- Disease/Condition
- Asthma,COPD
- Drug/Device/Intervention
- Spiromax (budesonide/formoterol)
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Consorzio Futuro in Ricerca
- Location
- Cassano delle Murge,Ferrara,Tradate, Italy
- Phase
- N/A
- Start date
- Apr 01, 2016
- End date
- Jan 01, 2018
- Enrollment
- 84 participants
Usability of Spiromax , Turbuhaler and Diskus devices
This is a randomized, multi-center, active-controlled, repeated measures design study in male
 and female patients 60 years of age and older with persistent asthma or COPD.
 
 Study will be conducted in 4 Italian University/Hospital Centers: Ferrara, Parma, Cassano
 delle Murge (Ba), Tradate.
 
 The primary efficacy parameter of the study is inhaler device usability (expressed as total
 number of repeated attempts required to achieve optimal use).
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT02757209
- Type
- Device Trial
Access comprehensive clinical trial information for NCT02757209 through Pure Global AI's free database. This phase not specified trial is sponsored by Consorzio Futuro in Ricerca and is currently Completed. The study focuses on Asthma,COPD. Target enrollment is 84 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.